Self-report and clinician-rated measures of depression severity: Can one replace the other?

Depression and Anxiety

Volumn 29, Issue 12, 2012, Pages 1043-1049

  Uher, Rudolf ^a,b   Perlis, Roy H ^c   Placentino, Anna ^d,e,f   Dernovšek, Mojca Zvezdana ^g   Henigsberg, Neven ^h   Mors, Ole ⁱ   Maier, Wolfgang ^j   McGuffin, Peter ^b   Farmer, Anne ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d Department of Mental Health   (Italy)

^e IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g University Psychiatric Clinic   (Slovenia)

^h UNIVERSITY OF ZAGREB   (Croatia)

ⁱ AARHUS UNIVERSITY HOSPITAL   (Denmark)

^j UNIVERSITY OF BONN   (Germany)

more..

Author keywords

antidepressants; assessment diagnosis; clinical trials; depression; mood disorders; treatment

Indexed keywords

CITALOPRAM; ESCITALOPRAM; NORTRIPTYLINE;

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; PREDICTION; PRIORITY JOURNAL; QUICK INVENTORY OF DEPRESSIVE SYMPTOMATOLOGY; SELF REPORT; TREATMENT OUTCOME;

ADULT; AGED; ANTIDEPRESSIVE AGENTS; CITALOPRAM; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; NORTRIPTYLINE; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SELF REPORT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84870564491     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.21993     Document Type: Article

References (50)

1. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000; 157: 1-45.
2. Gelenberg AJ,. A review of the current guidelines for depression treatment. J Clin Psychiatry 2010; 71: e15
3. National Institute for Clinical Excellence. The treatment and management of depression in adults. London, UK: National Institute for Clinical Excellence (NICE), Department of Health; 2009.
4. Nutt DJ,. Highlights of the international consensus statement on major depressive disorder. J Clin Psychiatry 2011; 72: e21
5. Adli M, Bauer M, Rush AJ,. Algorithms and collaborative-care systems for depression: are they effective and why? A systematic review. Biol Psychiatry 2006; 59: 1029-1038. (Pubitemid 43849663)
6. Cameron IM, Cardy A, Crawford JR, et al. Measuring depression severity in general practice: discriminatory performance of the PHQ-9, HADS-D, and BDI-II. Br J Gen Pract 2011; 61: e419-e426.
7. Moller HJ,. Rating depressed patients: observer- vs self-assessment. Eur Psychiatry 2000; 15: 160-172. (Pubitemid 30350552)
8. Katzelnick DJ, Duffy FF, Chung H, Regier DA, Rae DS, Trivedi MH,. Depression outcomes in psychiatric clinical practice: using a self-rated measure of depression severity. Psychiatr Serv 2011; 62: 929-935.
9. Rush AJ, Carmody TJ, Ibrahim HM, et al. Comparison of self-report and clinician ratings on two inventories of depressive symptomatology. Psychiatr Serv 2006; 57: 829-837. (Pubitemid 43846295)
10. Trivedi MH,. Tools and strategies for ongoing assessment of depression: a measurement-based approach to remission. J Clin Psychiatry 2009; 70 (Suppl 6): 26-31.
11. Beck AT, Ward CH, Mandelson M, Mock J, Erbaugh J,. An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
12. Richter P, Werner J, Bastine R, Heerlein A, Kick H, Sauer H,. Measuring treatment outcome by the Beck Depression Inventory. Psychopathology 1997; 30: 234-240. (Pubitemid 27296403)
13. Moller HJ, von Zerssen D,. Self-rating procedures in the evaluation of antidepressants. Psychopathology 1995; 28: 291-306.
14. Carroll BJ, Feinberg M, Smouse PE, Rawson SG, Greden JF,. The Carroll rating scale for depression. I. Development, reliability and validation. Br J Psychiatry 1981; 138: 194-200. (Pubitemid 11136936)
15. Svanborg P, Asberg M,. A comparison between the Beck Depression Inventory (BDI) and the self-rating version of the Montgomery Asberg Depression Rating Scale (MADRS). J Affect Disord 2001; 64: 203-216. (Pubitemid 32324213)
16. Carter JD, Frampton CM, Mulder RT, Luty SE, Joyce PR,. The relationship of demographic, clinical, cognitive and personality variables to the discrepancy between self and clinician rated depression. J Affect Disord 2010; 124: 202-206.
17. Fava GA, Kellner R, Lisansky J, Park S, Perini GI, Zielezny M,. Rating depression in normals and depressives: observer versus self-rating scales. J Affect Disord 1986; 11: 29-33. (Pubitemid 16045972)
18. Feinberg M, Carroll BJ, Smouse PE, Rawson SG,. The Carroll rating scale for depression. III. Comparison with other rating instruments. Br J Psychiatry 1981; 138: 205-209. (Pubitemid 11136938)
19. Prusoff BA, Klerman GL, Paykel ES,. Concordance between clinical assessments and patients' self-report in depression. Arch Gen Psychiatry 1972; 26: 546-552.
20. Uher R, Farmer A, Maier W, et al. Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol Med 2008; 38: 289-300. (Pubitemid 351156595)
21. Zimmerman M, Coryell W, Wilson S, Corenthal C,. Evaluation of symptoms of major depressive disorder. Self-report vs. clinician ratings. J Nerv Ment Dis 1986; 174: 150-153. (Pubitemid 16117405)
22. Carroll BJ, Fielding JM, Blashki TG,. Depression rating scales. A critical review. Arch Gen Psychiatry 1973; 28: 361-366.
23. Schotte CK, Maes M, Cluydts R, De DD, Cosyns P,. Construct validity of the Beck Depression Inventory in a depressive population. J Affect Disord 1997; 46: 115-125. (Pubitemid 28037483)
24. Corruble E, Legrand JM, Zvenigorowski H, Duret C, Guelfi JD,. Concordance between self-report and clinician's assessment of depression. J Psychiatr Res 1999; 33: 457-465. (Pubitemid 29392694)
25. Domken M, Scott J, Kelly P,. What factors predict discrepancies between self and observer ratings of depression? J Affect Disord 1994; 31: 253-259. (Pubitemid 24254708)
26. Cuijpers P, Li J, Hofmann SG, Andersson G,. Self-reported versus clinician-rated symptoms of depression as outcome measures in psychotherapy research on depression: a meta-analysis. Clin Psychol Rev 2010; 30: 768-778.
27. Greenberg RP, Bornstein RF, Greenberg MD, Fisher S,. A meta-analysis of antidepressant outcome under "blinder" conditions. J Consult Clin Psychol 1992; 60: 664-669.
28. Enns MW, Larsen DK, Cox BJ,. Discrepancies between self and observer ratings of depression. The relationship to demographic, clinical and personality variables. J Affect Disord 2000; 60: 33-41. (Pubitemid 30625242)
29. Rane LJ, Fekadu A, Wooderson S, Poon L, Markopoulou K, Cleare AJ,. Discrepancy between subjective and objective severity in treatment-resistant depression: prediction of treatment outcome. J Psychiatr Res 2010; 44: 1082-1087.
30. Hamilton M,. Development of a rating scale for primary depressive illness. Br J Clin Psychol 1967; 6: 278-296.
31. Bagby RM, Ryder AG, Schuller DR, Marshall MB,. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? Am J Psychiatry 2004; 161: 2163-2177. (Pubitemid 39587278)
32. Trajkovic G, Starcevic V, Latas M, et al. Reliability of the Hamilton Rating Scale for Depression: a meta-analysis over a period of 49 years. Psychiatry Res 2011; 189: 1-9.
33. Montgomery SA, Asberg M,. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
34. Bernstein IH, Rush AJ, Stegman D, Macleod L, Witte B, Trivedi MH,. A Comparison of the QIDS-C16, QIDS-SR16, and the MADRS in an adult outpatient clinical sample. CNS Spectr 2010; 15: 458-468.
35. Carmody TJ, Rush AJ, Bernstein I, et al. The Montgomery Asberg and the Hamilton ratings of depression: a comparison of measures. Eur Neuropsychopharmacol 2006; 16: 601-611. (Pubitemid 44716667)
36. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC; 2000.
37. Rush AJ, Bernstein IH, Trivedi MH, et al. An evaluation of the quick inventory of depressive symptomatology and the hamilton rating scale for depression: a sequenced treatment alternatives to relieve depression trial report. Biol Psychiatry 2006; 59: 493-501. (Pubitemid 43320536)
38. Martinsen EW, Friis S, Hoffart A,. Assessment of depression: comparison between Beck Depression Inventory and subscales of Comprehensive Psychopathological Rating Scale. Acta Psychiatr Scand 1995; 92: 460-463.
39. Rush AJ, Trivedi MH, Ibrahim HM, et al. The 16-item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression. Biol Psychiatry 2003; 54: 573-583. (Pubitemid 37289444)
40. Wing JK, Sartorius N, Ustin TB,. Diagnosis and Clinical Measurement in Psychiatry. A Reference Manual for SCAN. Geneva, Switzerland: World Health Organization; 1998.
41. Uher R, Maier W, Hauser J, et al. Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br J Psychiatry 2009; 194: 252-259.
42. Uher R, Farmer A, Henigsberg N, et al. Adverse reactions to antidepressants. Br J Psychiatry 2009; 195: 202-210.
43. Uher R, Muthen B, Souery D, et al. Trajectories of change in depression severity during treatment with antidepressants. Psychol Med 2010; 40: 1367-1377.
44. Uher R, Dernovsek MZ, Mors O, et al. Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline. J Affect Disord 2011; 132: 112-120.
45. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006; 163: 28-40. (Pubitemid 43050100)
46. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-1917. (Pubitemid 44807782)
47. Gueorguieva R, Krystal JH,. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004; 61: 310-317. (Pubitemid 38295833)
48. Mallinckrodt CH, Sanger TM, Dube S, et al. Assessing and interpreting treatment effects in longitudinal clinical trials with missing data. Biol Psychiatry 2003; 53: 754-760. (Pubitemid 39658489)
49. Gilbody SM, House AO, Sheldon TA,. Psychiatrists in the UK do not use outcomes measures. National survey. Br J Psychiatry 2002; 180: 101-103. (Pubitemid 34142777)
50. Uher R, Perlis RH, Henigsberg N, et al. Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms. Psychol Med 2012; 45: 967-980.